The global Anti-inflammatory Therapy market was valued at US$ 110540 million in 2023 and is anticipated to reach US$ 168750 million by 2030, witnessing a CAGR of 6.1% during the forecast period 2024-2030.

Anti-inflammatory Therapy Market

Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Anti-inflammatory Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-inflammatory Therapy.

Report Scope

The Anti-inflammatory Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-inflammatory Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Anti-inflammatory Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Anti-inflammatory Therapy Market Report

Report Metric	Details
Report Name	Anti-inflammatory Therapy Market
Accounted market size in 2023	US$ 110540 million
Forecasted market size in 2030	US$ 168750 million
CAGR	6.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Corticosteroids Anti-inflammatory Biologics Non-Steroidal Anti-inflammatory Drugs Others
Segment by Application	Respiratory Diseases Arthritis Gastroenterology Dermatology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-inflammatory Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Anti-inflammatory Therapy Market growing?

Ans: The Anti-inflammatory Therapy Market witnessing a CAGR of 6.1% during the forecast period 2024-2030.

What is the Anti-inflammatory Therapy Market size in 2030?

Ans: The Anti-inflammatory Therapy Market size in 2030 will be US$ 168750 million.

Who are the main players in the Anti-inflammatory Therapy Market report?

Ans: The main players in the Anti-inflammatory Therapy Market are AbbVie, Johnson & Johnson, Amgen Inc, AstraZeneca PLC, Pfizer, Inc, Novartis, Roche, Merck, Sanofi, GlaxoSmithKline, Sun Pharmaceutical Industries Ltd, TEVA

What are the Application segmentation covered in the Anti-inflammatory Therapy Market report?

Ans: The Applications covered in the Anti-inflammatory Therapy Market report are Respiratory Diseases, Arthritis, Gastroenterology, Dermatology, Others

What are the Type segmentation covered in the Anti-inflammatory Therapy Market report?

Ans: The Types covered in the Anti-inflammatory Therapy Market report are Corticosteroids, Anti-inflammatory Biologics, Non-Steroidal Anti-inflammatory Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Corticosteroids

1.2.3 Anti-inflammatory Biologics

1.2.4 Non-Steroidal Anti-inflammatory Drugs

1.2.5 Others

1.3 Market by Application

1.3.1 Global Anti-inflammatory Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Respiratory Diseases

1.3.3 Arthritis

1.3.4 Gastroenterology

1.3.5 Dermatology

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Anti-inflammatory Therapy Market Perspective (2019-2030)

2.2 Anti-inflammatory Therapy Growth Trends by Region

2.2.1 Global Anti-inflammatory Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Anti-inflammatory Therapy Historic Market Size by Region (2019-2024)

2.2.3 Anti-inflammatory Therapy Forecasted Market Size by Region (2025-2030)

2.3 Anti-inflammatory Therapy Market Dynamics

2.3.1 Anti-inflammatory Therapy Industry Trends

2.3.2 Anti-inflammatory Therapy Market Drivers

2.3.3 Anti-inflammatory Therapy Market Challenges

2.3.4 Anti-inflammatory Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Anti-inflammatory Therapy Players by Revenue

3.1.1 Global Top Anti-inflammatory Therapy Players by Revenue (2019-2024)

3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Anti-inflammatory Therapy Revenue

3.4 Global Anti-inflammatory Therapy Market Concentration Ratio

3.4.1 Global Anti-inflammatory Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2023

3.5 Anti-inflammatory Therapy Key Players Head office and Area Served

3.6 Key Players Anti-inflammatory Therapy Product Solution and Service

3.7 Date of Enter into Anti-inflammatory Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-inflammatory Therapy Breakdown Data by Type

4.1 Global Anti-inflammatory Therapy Historic Market Size by Type (2019-2024)

4.2 Global Anti-inflammatory Therapy Forecasted Market Size by Type (2025-2030)

5 Anti-inflammatory Therapy Breakdown Data by Application

5.1 Global Anti-inflammatory Therapy Historic Market Size by Application (2019-2024)

5.2 Global Anti-inflammatory Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Anti-inflammatory Therapy Market Size (2019-2030)

6.2 North America Anti-inflammatory Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Anti-inflammatory Therapy Market Size by Country (2019-2024)

6.4 North America Anti-inflammatory Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Anti-inflammatory Therapy Market Size (2019-2030)

7.2 Europe Anti-inflammatory Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Anti-inflammatory Therapy Market Size by Country (2019-2024)

7.4 Europe Anti-inflammatory Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Anti-inflammatory Therapy Market Size (2019-2030)

8.2 Asia-Pacific Anti-inflammatory Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Anti-inflammatory Therapy Market Size (2019-2030)

9.2 Latin America Anti-inflammatory Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Anti-inflammatory Therapy Market Size by Country (2019-2024)

9.4 Latin America Anti-inflammatory Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Anti-inflammatory Therapy Market Size (2019-2030)

10.2 Middle East & Africa Anti-inflammatory Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Anti-inflammatory Therapy Introduction

11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction

11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Amgen Inc

11.3.1 Amgen Inc Company Detail

11.3.2 Amgen Inc Business Overview

11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction

11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.3.5 Amgen Inc Recent Development

11.4 AstraZeneca PLC

11.4.1 AstraZeneca PLC Company Detail

11.4.2 AstraZeneca PLC Business Overview

11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction

11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.4.5 AstraZeneca PLC Recent Development

11.5 Pfizer, Inc

11.5.1 Pfizer, Inc Company Detail

11.5.2 Pfizer, Inc Business Overview

11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction

11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.5.5 Pfizer, Inc Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis Anti-inflammatory Therapy Introduction

11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.6.5 Novartis Recent Development

11.7 Roche

11.7.1 Roche Company Detail

11.7.2 Roche Business Overview

11.7.3 Roche Anti-inflammatory Therapy Introduction

11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.7.5 Roche Recent Development

11.8 Merck

11.8.1 Merck Company Detail

11.8.2 Merck Business Overview

11.8.3 Merck Anti-inflammatory Therapy Introduction

11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.8.5 Merck Recent Development

11.9 Sanofi

11.9.1 Sanofi Company Detail

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Anti-inflammatory Therapy Introduction

11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.9.5 Sanofi Recent Development

11.10 GlaxoSmithKline

11.10.1 GlaxoSmithKline Company Detail

11.10.2 GlaxoSmithKline Business Overview

11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction

11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.10.5 GlaxoSmithKline Recent Development

11.11 Sun Pharmaceutical Industries Ltd

11.11.1 Sun Pharmaceutical Industries Ltd Company Detail

11.11.2 Sun Pharmaceutical Industries Ltd Business Overview

11.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction

11.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.11.5 Sun Pharmaceutical Industries Ltd Recent Development

11.12 TEVA

11.12.1 TEVA Company Detail

11.12.2 TEVA Business Overview

11.12.3 TEVA Anti-inflammatory Therapy Introduction

11.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2019-2024)

11.12.5 TEVA Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Sun Pharmaceutical Industries Ltd.

TEVA

AbbVie

List of Tables

Table 1. Global Anti-inflammatory Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Corticosteroids

Table 3. Key Players of Anti-inflammatory Biologics

Table 4. Key Players of Non-Steroidal Anti-inflammatory Drugs

Table 5. Key Players of Others

Table 6. Global Anti-inflammatory Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Anti-inflammatory Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Anti-inflammatory Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Anti-inflammatory Therapy Market Share by Region (2019-2024)

Table 10. Global Anti-inflammatory Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Anti-inflammatory Therapy Market Share by Region (2025-2030)

Table 12. Anti-inflammatory Therapy Market Trends

Table 13. Anti-inflammatory Therapy Market Drivers

Table 14. Anti-inflammatory Therapy Market Challenges

Table 15. Anti-inflammatory Therapy Market Restraints

Table 16. Global Anti-inflammatory Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Anti-inflammatory Therapy Market Share by Players (2019-2024)

Table 18. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2023)

Table 19. Ranking of Global Top Anti-inflammatory Therapy Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Anti-inflammatory Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Anti-inflammatory Therapy Product Solution and Service

Table 23. Date of Enter into Anti-inflammatory Therapy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Anti-inflammatory Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Anti-inflammatory Therapy Revenue Market Share by Type (2019-2024)

Table 27. Global Anti-inflammatory Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Anti-inflammatory Therapy Revenue Market Share by Type (2025-2030)

Table 29. Global Anti-inflammatory Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Anti-inflammatory Therapy Revenue Market Share by Application (2019-2024)

Table 31. Global Anti-inflammatory Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Anti-inflammatory Therapy Revenue Market Share by Application (2025-2030)

Table 33. North America Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Anti-inflammatory Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Anti-inflammatory Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Anti-inflammatory Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Anti-inflammatory Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Anti-inflammatory Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Anti-inflammatory Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Anti-inflammatory Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Anti-inflammatory Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Anti-inflammatory Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Anti-inflammatory Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. AbbVie Company Detail

Table 49. AbbVie Business Overview

Table 50. AbbVie Anti-inflammatory Therapy Product

Table 51. AbbVie Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 52. AbbVie Recent Development

Table 53. Johnson & Johnson Company Detail

Table 54. Johnson & Johnson Business Overview

Table 55. Johnson & Johnson Anti-inflammatory Therapy Product

Table 56. Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 57. Johnson & Johnson Recent Development

Table 58. Amgen Inc Company Detail

Table 59. Amgen Inc Business Overview

Table 60. Amgen Inc Anti-inflammatory Therapy Product

Table 61. Amgen Inc Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 62. Amgen Inc Recent Development

Table 63. AstraZeneca PLC Company Detail

Table 64. AstraZeneca PLC Business Overview

Table 65. AstraZeneca PLC Anti-inflammatory Therapy Product

Table 66. AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 67. AstraZeneca PLC Recent Development

Table 68. Pfizer, Inc Company Detail

Table 69. Pfizer, Inc Business Overview

Table 70. Pfizer, Inc Anti-inflammatory Therapy Product

Table 71. Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 72. Pfizer, Inc Recent Development

Table 73. Novartis Company Detail

Table 74. Novartis Business Overview

Table 75. Novartis Anti-inflammatory Therapy Product

Table 76. Novartis Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 77. Novartis Recent Development

Table 78. Roche Company Detail

Table 79. Roche Business Overview

Table 80. Roche Anti-inflammatory Therapy Product

Table 81. Roche Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 82. Roche Recent Development

Table 83. Merck Company Detail

Table 84. Merck Business Overview

Table 85. Merck Anti-inflammatory Therapy Product

Table 86. Merck Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 87. Merck Recent Development

Table 88. Sanofi Company Detail

Table 89. Sanofi Business Overview

Table 90. Sanofi Anti-inflammatory Therapy Product

Table 91. Sanofi Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 92. Sanofi Recent Development

Table 93. GlaxoSmithKline Company Detail

Table 94. GlaxoSmithKline Business Overview

Table 95. GlaxoSmithKline Anti-inflammatory Therapy Product

Table 96. GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 97. GlaxoSmithKline Recent Development

Table 98. Sun Pharmaceutical Industries Ltd Company Detail

Table 99. Sun Pharmaceutical Industries Ltd Business Overview

Table 100. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Product

Table 101. Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 102. Sun Pharmaceutical Industries Ltd Recent Development

Table 103. TEVA Company Detail

Table 104. TEVA Business Overview

Table 105. TEVA Anti-inflammatory Therapy Product

Table 106. TEVA Revenue in Anti-inflammatory Therapy Business (2019-2024) & (US$ Million)

Table 107. TEVA Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Anti-inflammatory Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Anti-inflammatory Therapy Market Share by Type: 2023 VS 2030

Figure 3. Corticosteroids Features

Figure 4. Anti-inflammatory Biologics Features

Figure 5. Non-Steroidal Anti-inflammatory Drugs Features

Figure 6. Others Features

Figure 7. Global Anti-inflammatory Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Anti-inflammatory Therapy Market Share by Application: 2023 VS 2030

Figure 9. Respiratory Diseases Case Studies

Figure 10. Arthritis Case Studies

Figure 11. Gastroenterology Case Studies

Figure 12. Dermatology Case Studies

Figure 13. Others Case Studies

Figure 14. Anti-inflammatory Therapy Report Years Considered

Figure 15. Global Anti-inflammatory Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Anti-inflammatory Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Anti-inflammatory Therapy Market Share by Region: 2023 VS 2030

Figure 18. Global Anti-inflammatory Therapy Market Share by Players in 2023

Figure 19. Global Top Anti-inflammatory Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-inflammatory Therapy as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Anti-inflammatory Therapy Revenue in 2023

Figure 21. North America Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Anti-inflammatory Therapy Market Share by Country (2019-2030)

Figure 23. United States Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Anti-inflammatory Therapy Market Share by Country (2019-2030)

Figure 27. Germany Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Anti-inflammatory Therapy Market Share by Region (2019-2030)

Figure 35. China Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Anti-inflammatory Therapy Market Share by Country (2019-2030)

Figure 43. Mexico Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Anti-inflammatory Therapy Market Share by Country (2019-2030)

Figure 47. Turkey Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Anti-inflammatory Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. AbbVie Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 50. Johnson & Johnson Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 51. Amgen Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 52. AstraZeneca PLC Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 53. Pfizer, Inc Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 54. Novartis Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 55. Roche Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 56. Merck Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 57. Sanofi Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 58. GlaxoSmithKline Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 59. Sun Pharmaceutical Industries Ltd Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 60. TEVA Revenue Growth Rate in Anti-inflammatory Therapy Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions